Organon & Co. (OGN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 06, 2025

$15.48

P/E Ratio

3.07

Market Cap

$3.99B

Loading...
Description

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Metrics

Overview

  • HQJersey City, NJ
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerOGN
  • Price$15.48+0.26%

Trading Information

  • Market cap$3.99B
  • Float99.78%
  • Average Daily Volume (1m)4,698,690
  • Average Daily Volume (3m)3,299,888
  • EPS$5.07

Company

  • Revenue$6.41B
  • Rev growth (1yr)4.15%
  • Net income$359.00M
  • Gross margin58.34%
  • EBITDA margin29.01%
  • EBITDA$459.00M
  • EV$12.96B
  • EV/Revenue2.02
  • P/E3.07
  • P/S0.63
  • P/B8.09
Documents